DOCSLIB.ORG

Supplemental Table 1

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Symbol Gene name MIN6.EXO MIN6.M1 MIN6.M2 MIN6.M3 MIN6.M4 A2m alpha-2-macroglobulin A2m Acat1 acetyl-Coenzyme A acetyltransferase 1 Acat1 Acly ATP citrate lyase Acly Acly Acly Act Actin Act Act Act Act Aga aspartylglucosaminidase Aga Ahcy S-adenosylhomocysteine hydrolase Ahcy Alb Albumin Alb Alb Alb Aldoa aldolase A, fructose-bisphosphate Aldoa Anxa5 Annexin A5 Anxa5 AP1 Adaptor-related protein complex AP1 AP2 Adaptor protein complex AP2 Arf1 ADP-ribosylation factor 1 Arf1 Atp1a1 ATPase Na/K transpoting Atp1a1 ATP1b1 Na/K ATPase beta subunit ATP1b1 ATP6V1 ATPase, H+ transporting.. ATP6V1 ATP6v1 ATP6v1 Banf1 Barrier to autointegration factor Banf1 Basp1 brain abundant, memrane signal protein 1 Basp1 C3 complement C3 C3 C3 C3 C4 Complement C4 C4 C4 C4 Calm2 calmodulin 2 (phosphorylase kinase, delta) Calm2 Capn5 Calpain 5 Capn5 Capn5 Cct5 chaperonin subunit 5 Cct5 Cct8 chaperonin subunit 8 Cct8 CD147 basigin CD147 CD63 CD63 CD63 CD81 CD81 CD81 CD81 CD81 CD81 CD81 CD82 CD82 CD82 CD82 CD90.2 thy1.2 CD90.2 CD98 Slc3a2 CD98 CD98 Cdc42 Cell division cycle 42 Cdc42 Cfl1 Cofilin 1 Cfl1 Cfl1 Chmp4b chromatin modifying protein 4B Chmp4b Chmp5 chromatin modifying protein 5 Chmp5 Clta clathrin, light polypeptide A Clta Cltc Clathrin Hc Cltc Cltc Cltc Cltc Clu clusterin Clu Col16a1 collagen 16a1 Col16a1 Col2 Collagen type II Col2a1 Col2 Col6 Collagen type VI alpha 3 Col6a3 Col6 CpE carboxypeptidase E CpE CpE CpE, CpH CpE CpE Cspg4 Chondroitin sulfate proteoglycan 4 Cspg4 CyCAP Cyclophilin C-associated protein CyCAP CyCAP Dnpep aspartyl aminopeptidase Dnpep Dstn destrin Dstn EDIL3 EGF-like repeat discoidin.. EDIL3 EDIL3 Edil3 Eef Eukaryotic elongation factor 2 Eef2 Eef EEF1A1 elongation factor Tu EEF1A1 EEF1A1 EEF1a1 Eif4a1 eukaryotic translation initiation factor 4A1 Eif4a1 Enddo1 Endonuclease domain containing 1 Enddo1 Eno Enolase Eno Eno Enpep glutamyl aminopeptidase Enpep Env Envelope protein Env Env Env F2 Coagulation factor II F2 F2 Fbln1 Fibulin Fbln1 Fbln5 Fignl1 fidgetin-like 1 Fignl1 Flot1 flotillin 1 Flot1 Fn1 Fibronectin Fn1 Fn1 Fn1 Fn1 Fn1 Ftl1 Ferritin light chain Ftl1 Ftl1 Fth1 ferritin heavy chain 1 Fth1 GAPDH glyceraldehyde-3-phosphate dehydrogenase GAPDH GAPDH GAPDH GAPDH GAPDH gag-pol gag-pro-pol polyprotein gag-pol gag gag-pol gag-pol gag-pol Glut1 glucose transporter 1 Glut1 Glut1 Glut1 Gnai2 guanine nucleotide binding protein (G protein) Gnai2 Gnao1 guanine nucleotide binding protein Gnao1 Gnas GTP-binding protein alpha-s Gnas GNPTG N-acetylglucosamine-1-phosphate transferase GNPTG GPI glucose phosphate isomerase GPI Grem1 Gremlin 1 Grem1 Grem1 Gsn Gelsolin, cytosolic Gsn Gstp1 glutathione S-transferase, pi 1 Gstp1 H-2D MHC class I H-2D H-2D H-2K MHC class I H-2K H-2K Hba1 Hemoglobin alpha Hba1 Hba1 Hbb Hemoglobin beta Hbb Hbb Hbb-y Hemoglobin Y Hbb-y Hbb-y Hbb-y Hbb-y Hbb-y Histones Histone clusters Histones Histones Histones Hnrnp heterogeneous nuclear ribonucleoprotein Hnrnp Hras1 Harvey rat sarcoma virus oncogene 1 Hras1 HSP heat shock protein family HSP HSP HSP HSP HSP40 DnaJ HSP40 IGF2 Insulin-like growth factor 2 IGF2 Igsf8 Ig superfamily receptor PGRL Igsf8 Igsf8 Igsf8 Ins2 Insulin II Ins2 ITIH3 inter-alpha trypsin inhibitor ITIH3 ITIH3 Kpnb1 Importin/karyopherin Kpnb1 Krt Keratins Krt Krt Krt Krt Krt Lbp lipopolysaccharide binding protein LDHA Lactate dehydrogenase A LDHA LPL Lipoprotein lipase LPL LPL LPL M6PR Mannose-6-phasphate receptor M6PR M6PR MDH Malate dehydrogenase MDH Mfge8 milk fat globule-EGF factor 8 protein Mfge8 MIF Migration inhibitory factor MIF MVP Major vault protein MVP MVP MYH9 Myosin Heavy chain 9 MYH9 MYH9 MYH9 MYH9 MYH10 Myosin Heavy chain 10 MYH10 MYH10 Myl Myosin light chain Myl Ncl nucleolin Ncl NonO non-POU-domain-containing, octamer binding protein Nsf N-ethylmaleimide sensitive fusion pr Nsf Nsfl1c NSFL1 (p97) cofactor (p47) Nsfl1c Oxtr Oxytocin receptor Oxtr P4hb prolyl 4-hydroxylase, beta polypeptide P4hb Pabp Poly(A) binding protein Pabp Pabp Pabp Pacsin2 protein kinase C and casein kinase substrate Pacsin2 PC1 proprotein convertase Kexin PC1 PC1 PC2 Proprotein convertase Kexin PC2 PC2 PC2 PC2 Pcbp1 poly(rC) binding protein 1 Pcbp1 Pck2 Phosphoenolpyruvate carboxykinase 2 Pck2 Pdcd6ip Alix Pdcd6ip Pdcd6ip Pdcd6ip Pdia6 protein disulfide isomerase associated 6 Pdia6 Pdyn prodynorphin Pdyn PGK Phosphoglycerate kinase PGK PGK Phgdh 3-phosphoglycerate dehydrogenase Phgdh PKM2 pyruvate kinase PKM2 PKM2 PKM2 Plod1 Lysyl hydroxylase 1 Plod1 Plp2 proteolipid protein 2 Plp2 Postn Periostin Postn Postn Postn PPIA peptidylprolyl isomerase A PPIA PPIA Ppp1cc protein phosphatase 1 Ppp1cc Ppp1cc Prdx1 peroxiredoxin 1 Prdx1 Prnp prion protein Prnp Prss1 Protease, Serine 1 Prss1 Prss1 Prss1 Prss1 Psmc2 proteasome (prosome, macropain) 26S Psmc2 Purb purine rich element binding protein B Purb Pzp Pregnancy zone protein Pzp Pzp Rab Rab family Rab Rab Rab7 Rab 7 Rab7 Rabep1 rabaptin, RAB GTPase binding effector protein 1 Rabep1 Rac1 RAS-related C3 botulinum substrate 1 Rac1 Rap1A Rap1A Rap1A Rap1a Rhoc ras homolog gene family, member C Rhoc Rpl11 ribosomal protein L11 Rpl11 Rplp0, l13 ribosomal protein, large, P0 Rplp0, l13 Rps5 5S ribosomal protein Rps5 Rps8, 11, 13Ribosomal protein S Rps8, 11, 13 Rpsa ribosomal protein SA, Laminin Receptor Rpsa Rpsa Scg2 secretogranin II Scg2 Scramp3 Secretory carrier membrane protein 3 Scramp3 Sdcbp Syntenin Sdcbp Sdcbp Sec31a protein transporting Sec31a Sec31a Sec31a Serpinf1 serine peptidase inhibitor, Caspin Serpinf1 Sh3gl1 SH3 domain Grb2-like 1 Sh3gl1 Sh3gl1 Sil1 ER chaperone SIL1 homolog Sil1 Slit1 Slit homology 1 Slit1 Slc16a1 Solute carrier family 16a1 Slc16a1 Slc1a5 Insulin-activated aa transporter Slc1a5 Slc2a3 Solute carrier family 2a3 Slc2a3 Slc38a5 Slc38a5 Slc38a5 Slc7a2 Slc7a2 Slc7a2 Slc7a5 Solute carrier family 7a5 Slc7a5 Slc7a5 Snrpd1 small nuclear ribonucleoprotein D1 polypeptide 16kDa Snx18 sorting nexin 18 Snx18 Spock2 Sparc/osteonectin… Spock2 Spp2 secreted phosphoprotein 2 Spp2 Sub1 RNA polymerase II transcriptional coactivator Sub1 Tagln2 transgelin 2 Tagln2 TFRC Transferrin receptor TFRC Tfrc Tfrc TGFbi TGF beta induced TGFbi Thbs1 Thrombospondin 1 Thbs1 Thbs1 Thbs1 Tln1 Talin 1 Tln1 TPI1 Triosephosphate isomerase TPI1 TPI1 Tpp2 Tripeptidyl peptidase II Tpp2 Tpt1 tumor protein, translationally-controlled 1 Tpt1 Trove2 60KD ribonuceoprotein SSA/Ro Trove2 Trove2 Try4 Trypsin 4 Try4 Try4 Try4 Try10 Trypsin 10 Try10 Try10 trypsinogen trypsinogen7 7 trypsinogen 7 Tsg101 tumor susceptibility gene 101 Tsg101 Tspan6 tetraspanin 6 Tspan6 Tspan7 tetraspanin 7 Tspan7 Tspan7 Tuba alpha-Tubulin Tuba Tuba Tuba Tuba Tuba Tubb beta Tubuln Tubb Tubb Tubb Tub6 Ub Ubiquitin famuily Ub Ub Ub Ub Ub Uba1 ubiquitin-like modifier activating enzyme 1 Uba1 UbE2N ubiquitin-conjugating enzyme E2N UbE2N ValRS Valyl-tRNA synthetase ValRS Vamp2 vesicle-associated membrane protein 2 Vamp2 Vcp Valosin containing protein Vcp Vcp Vcp VcpP97 Chain A VcpP97 VcpP97 VcpP97 Vps25 Vacuolar protein sorting 25 Vps25 Vps28 Vacuolar protein sorting 28 Vps28 Vps37 Vacuolar protein sorting 37B VPS37 Vps37 Vstm2l V-set and transmembrane domain containing 2-like Vstm2l Wars tryptophanyl-tRNA synthetase Wars Ybx1 Y Box binding protein Ybx1 Ybx1 YWHAE YW -monoxygenase act protein YWHAE YWHAZ 14-3-3 YWHAZ SUPPLEMENTAL TABLE. Mass spectrometry analysis of proteins in MIN6.EXO. EXO prepared from MIN6 insulinoma cell culture supernatant (50 µg) was submitted to the mass spectrometry facility in the Scripps Research Institute (San Diego, CA) for protein identification. The result is shown in the third column, MIN.EXO. For column #4-7, total 100 µg of EXO proteins were separated on a 10% Tris-HCl polyacrylamide gel. The gel was divided into 4 slices, M1, M2, M3 and M4, as indicated in Fig. 1B. Each slice was analyzed in mass spectrometry, and protein contents are listed in the rest columns labeled as MIN6.M1, MIN6.M2, MIN6.M3 and MIN6.M4, respectively for each slice. .
Recommended publications
  • Transcriptomic Analysis of Human Brain Microvascular Endothelial

    Transcriptomic Analysis of Human Brain Microvascular Endothelial

    www.nature.com/scientificreports OPEN Transcriptomic analysis of human brain microvascular endothelial cells exposed to laminin binding protein (adhesion lipoprotein) and Streptococcus pneumoniae Irene Jiménez‑Munguía1, Zuzana Tomečková1, Evelína Mochnáčová1, Katarína Bhide1, Petra Majerová2 & Mangesh Bhide1,2* Streptococcus pneumoniae invades the CNS and triggers a strong cellular response. To date, signaling events that occur in the human brain microvascular endothelial cells (hBMECs), in response to pneumococci or its surface adhesins are not mapped comprehensively. We evaluated the response of hBMECs to the adhesion lipoprotein (a laminin binding protein—Lbp) or live pneumococci. Lbp is a surface adhesin recently identifed as a potential ligand, which binds to the hBMECs. Transcriptomic analysis was performed by RNA‑seq of three independent biological replicates and validated with qRT‑PCR using 11 genes. In total 350 diferentially expressed genes (DEGs) were identifed after infection with S. pneumoniae, whereas 443 DEGs when challenged with Lbp. Total 231 DEGs were common in both treatments. Integrative functional analysis revealed participation of DEGs in cytokine, chemokine, TNF signaling pathways and phagosome formation. Moreover, Lbp induced cell senescence and breakdown, and remodeling of ECM. This is the frst report which maps complete picture of cell signaling events in the hBMECs triggered against S. pneumoniae and Lbp. The data obtained here could contribute in a better understanding of the invasion of pneumococci across BBB and underscores role of Lbp adhesin in evoking the gene expression in neurovascular unit. Streptococcus pneumoniae (also known as pneumococcus) is a life-threatening pathogen responsible for high morbidity and mortality rates worldwide1. It can cross the blood–brain barrier (BBB) and cause meningitis, commonly known as pneumococcal meningitis, a rare but life-threatening medical emergency.
  • The Rise and Fall of the Bovine Corpus Luteum

    The Rise and Fall of the Bovine Corpus Luteum

    University of Nebraska Medical Center DigitalCommons@UNMC Theses & Dissertations Graduate Studies Spring 5-6-2017 The Rise and Fall of the Bovine Corpus Luteum Heather Talbott University of Nebraska Medical Center Follow this and additional works at: https://digitalcommons.unmc.edu/etd Part of the Biochemistry Commons, Molecular Biology Commons, and the Obstetrics and Gynecology Commons Recommended Citation Talbott, Heather, "The Rise and Fall of the Bovine Corpus Luteum" (2017). Theses & Dissertations. 207. https://digitalcommons.unmc.edu/etd/207 This Dissertation is brought to you for free and open access by the Graduate Studies at DigitalCommons@UNMC. It has been accepted for inclusion in Theses & Dissertations by an authorized administrator of DigitalCommons@UNMC. For more information, please contact [email protected]. THE RISE AND FALL OF THE BOVINE CORPUS LUTEUM by Heather Talbott A DISSERTATION Presented to the Faculty of the University of Nebraska Graduate College in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy Biochemistry and Molecular Biology Graduate Program Under the Supervision of Professor John S. Davis University of Nebraska Medical Center Omaha, Nebraska May, 2017 Supervisory Committee: Carol A. Casey, Ph.D. Andrea S. Cupp, Ph.D. Parmender P. Mehta, Ph.D. Justin L. Mott, Ph.D. i ACKNOWLEDGEMENTS This dissertation was supported by the Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture (NIFA) Pre-doctoral award; University of Nebraska Medical Center Graduate Student Assistantship; University of Nebraska Medical Center Exceptional Incoming Graduate Student Award; the VA Nebraska-Western Iowa Health Care System Department of Veterans Affairs; and The Olson Center for Women’s Health, Department of Obstetrics and Gynecology, Nebraska Medical Center.
  • 1 Evidence for Gliadin Antibodies As Causative Agents in Schizophrenia

    1 Evidence for Gliadin Antibodies As Causative Agents in Schizophrenia

    1 Evidence for gliadin antibodies as causative agents in schizophrenia. C.J.Carter PolygenicPathways, 20 Upper Maze Hill, Saint-Leonard’s on Sea, East Sussex, TN37 0LG [email protected] Tel: 0044 (0)1424 422201 I have no fax Abstract Antibodies to gliadin, a component of gluten, have frequently been reported in schizophrenia patients, and in some cases remission has been noted following the instigation of a gluten free diet. Gliadin is a highly immunogenic protein, and B cell epitopes along its entire immunogenic length are homologous to the products of numerous proteins relevant to schizophrenia (p = 0.012 to 3e-25). These include members of the DISC1 interactome, of glutamate, dopamine and neuregulin signalling networks, and of pathways involved in plasticity, dendritic growth or myelination. Antibodies to gliadin are likely to cross react with these key proteins, as has already been observed with synapsin 1 and calreticulin. Gliadin may thus be a causative agent in schizophrenia, under certain genetic and immunological conditions, producing its effects via antibody mediated knockdown of multiple proteins relevant to the disease process. Because of such homology, an autoimmune response may be sustained by the human antigens that resemble gliadin itself, a scenario supported by many reports of immune activation both in the brain and in lymphocytes in schizophrenia. Gluten free diets and removal of such antibodies may be of therapeutic benefit in certain cases of schizophrenia. 2 Introduction A number of studies from China, Norway, and the USA have reported the presence of gliadin antibodies in schizophrenia 1-5. Gliadin is a component of gluten, intolerance to which is implicated in coeliac disease 6.
  • In Vitro Differentiation of Bone Marrow Mesenchymal Stem Cells Into Endometrial Epithelial Cells in Mouse: a Proteomic Analysis

    In Vitro Differentiation of Bone Marrow Mesenchymal Stem Cells Into Endometrial Epithelial Cells in Mouse: a Proteomic Analysis

    Int J Clin Exp Pathol 2014;7(7):3662-3672 www.ijcep.com /ISSN:1936-2625/IJCEP0000322 Original Article In vitro differentiation of bone marrow mesenchymal stem cells into endometrial epithelial cells in mouse: a proteomic analysis Qing Cong1,2, Bin Li1,2, Yisheng Wang1,2, Wenbi Zhang1,2, Mingjun Cheng1,2, Zhiyong Wu1,2, Xiaoyan Zhang1,2, Wei Jiang1,2, Congjian Xu1,2,3,4 1Obstetrics and Gynecology Hospital of Fudan University, 2Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, 3Department of Obstetrics and Gynecology of Shanghai Medical School, 4Institute of Biomedical Sciences, Fudan University, Shanghai, P.R. China Received March 24, 2014; Accepted June 23, 2014; Epub June 15, 2014; Published July 1, 2014 Abstract: Objective: Mouse bone marrow mesenchymal stem cells (BMSCs) have been demonstrated to differenti- ate into female endometrial epithelial cells (EECs) in vivo. Our previous studies demonstrated that BMSCs can differentiate in the direction of EECs when co-cultured with endometrial stromal cells in vitro. Here, we obtain and analyse differential proteins and their relevant pathways in the process of BMSCs differentiating into EECs by iso- baric tags for relative and absolute quantitation (iTRAQ) proteomic analysis. Methods: A 0.4-µm pore size indirect co- culture system was established with female mice endometrial stromal cells (EStCs) restricted in the upper Transwell chamber and BMSCs in the lower well plate. After indirect co-culture for several days, the BMSCs were revealed to progressively differentiate towards EECs in vitro. Then, four groups were divided according to different co-culture days with single culture groups of BMSCs as controls.
  • Table 1 Gene Name Increased Or Decreased in LTD

    Table 1 Gene Name Increased Or Decreased in LTD

    Table_1 gene_name increased or decreased in LTD protein_id description keep_supernatant keep_pellet comparison sample hit_annotation_methodpvalue fdr hit hit_annotation 2010300C02RIK increased E9Q3M9 Protein 2010300C02Rik OS=Mus musculus GN=2010300C02Rik PE=1 SV=1 TRUE TRUE NMDA - control pellet fdrtool 0,074667 0,584087 FALSE trend 2310035C23RIK|KIAA1468increased A0A087WSS1|E9QM90|Q148V7|Q148V7-2 Protein 2310035C23Rik OS=Mus musculus GN=2310035C23Rik PE=1 SV=1|Protein 2310035C23Rik OS=Mus musculusTRUE GN=2310035C23Rik PE=1 SV=2|LisH FALSE domain NMDAand HEAT - control repeat-containing protein KIAA1468 supernatant OS=Mus musculus GN=Kiaa1468 fdrtoolPE=1 SV=1|Isoform 0,080056 2 of 0,589077LisH domain FALSEand HEAT trend repeat-containing protein KIAA1468 OS=Mus musculus GN=Kiaa1468 ABR increased E9PUE7|Q5SSL4|Q5SSL4-2|Q5SSL4-3|Q5SSL4-4 Active breakpoint cluster region-related protein OS=Mus musculus GN=Abr PE=1 SV=1|Isoform 2 of Active breakpointTRUE cluster region-related protein TRUE OS=Mus musculus NMDA GN=Abr|Isoform - control 3 of Active breakpoint supernatant cluster region-related protein OS=Mus fdrtool musculus 0,08128 GN=Abr|Isoform 0,592743 4 of Active FALSE breakpoint trend cluster region-related protein OS=Mus musculus GN=Abr ADAM22 increased D3YUP9|Q9R1V6|Q9R1V6-10|Q9R1V6-11|Q9R1V6-12|Q9R1V6-13|Q9R1V6-14|Q9R1V6-15|Q9R1V6-17|Q9R1V6-4|Q9R1V6-5|Q9R1V6-6|Q9R1V6-7|Q9R1V6-8Disintegrin and metalloproteinase domain-containing protein 22 OS=Mus musculus GN=Adam22 PE=1 SV=1|DisintegrinFALSE and metalloproteinase domain-containing TRUE
  • Structure of Human Aspartyl Aminopeptidase Complexed With

    Structure of Human Aspartyl Aminopeptidase Complexed With

    Chaikuad et al. BMC Structural Biology 2012, 12:14 http://www.biomedcentral.com/1472-6807/12/14 RESEARCH ARTICLE Open Access Structure of human aspartyl aminopeptidase complexed with substrate analogue: insight into catalytic mechanism, substrate specificity and M18 peptidase family Apirat Chaikuad1, Ewa S Pilka1, Antonio De Riso2, Frank von Delft1, Kathryn L Kavanagh1, Catherine Vénien-Bryan2, Udo Oppermann1,3 and Wyatt W Yue1* Abstract Backround: Aspartyl aminopeptidase (DNPEP), with specificity towards an acidic amino acid at the N-terminus, is the only mammalian member among the poorly understood M18 peptidases. DNPEP has implicated roles in protein and peptide metabolism, as well as the renin-angiotensin system in blood pressure regulation. Despite previous enzyme and substrate characterization, structural details of DNPEP regarding ligand recognition and catalytic mechanism remain to be delineated. Results: The crystal structure of human DNPEP complexed with zinc and a substrate analogue aspartate-β- hydroxamate reveals a dodecameric machinery built by domain-swapped dimers, in agreement with electron microscopy data. A structural comparison with bacterial homologues identifies unifying catalytic features among the poorly understood M18 enzymes. The bound ligands in the active site also reveal the coordination mode of the binuclear zinc centre and a substrate specificity pocket for acidic amino acids. Conclusions: The DNPEP structure provides a molecular framework to understand its catalysis that is mediated by active site loop swapping, a mechanism likely adopted in other M18 and M42 metallopeptidases that form dodecameric complexes as a self-compartmentalization strategy. Small differences in the substrate binding pocket such as shape and positive charges, the latter conferred by a basic lysine residue, further provide the key to distinguishing substrate preference.
  • An Animal Model with a Cardiomyocyte-Specific Deletion of Estrogen Receptor Alpha: Functional, Metabolic, and Differential Netwo

    An Animal Model with a Cardiomyocyte-Specific Deletion of Estrogen Receptor Alpha: Functional, Metabolic, and Differential Netwo

    Washington University School of Medicine Digital Commons@Becker Open Access Publications 2014 An animal model with a cardiomyocyte-specific deletion of estrogen receptor alpha: Functional, metabolic, and differential network analysis Sriram Devanathan Washington University School of Medicine in St. Louis Timothy Whitehead Washington University School of Medicine in St. Louis George G. Schweitzer Washington University School of Medicine in St. Louis Nicole Fettig Washington University School of Medicine in St. Louis Attila Kovacs Washington University School of Medicine in St. Louis See next page for additional authors Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs Recommended Citation Devanathan, Sriram; Whitehead, Timothy; Schweitzer, George G.; Fettig, Nicole; Kovacs, Attila; Korach, Kenneth S.; Finck, Brian N.; and Shoghi, Kooresh I., ,"An animal model with a cardiomyocyte-specific deletion of estrogen receptor alpha: Functional, metabolic, and differential network analysis." PLoS One.9,7. e101900. (2014). https://digitalcommons.wustl.edu/open_access_pubs/3326 This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact [email protected]. Authors Sriram Devanathan, Timothy Whitehead, George G. Schweitzer, Nicole Fettig, Attila Kovacs, Kenneth S. Korach, Brian N. Finck, and Kooresh I. Shoghi This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/open_access_pubs/3326 An Animal Model with a Cardiomyocyte-Specific Deletion of Estrogen Receptor Alpha: Functional, Metabolic, and Differential Network Analysis Sriram Devanathan1, Timothy Whitehead1, George G. Schweitzer2, Nicole Fettig1, Attila Kovacs3, Kenneth S.
  • Genome-Wide Rnai Screens Identify Genes Required for Ricin and PE Intoxications

    Genome-Wide Rnai Screens Identify Genes Required for Ricin and PE Intoxications

    Developmental Cell Article Genome-Wide RNAi Screens Identify Genes Required for Ricin and PE Intoxications Dimitri Moreau,1 Pankaj Kumar,1 Shyi Chyi Wang,1 Alexandre Chaumet,1 Shin Yi Chew,1 He´ le` ne Chevalley,1 and Fre´ de´ ric Bard1,* 1Institute of Molecular and Cell Biology, 61 Biopolis Drive, Proteos, Singapore 138673, Singapore *Correspondence: [email protected] DOI 10.1016/j.devcel.2011.06.014 SUMMARY In the lumen of the ER, these toxins are thought to interact with elements of the ER-associated degradation (ERAD) pathway, Protein toxins such as Ricin and Pseudomonas which targets misfolded proteins in the ER for degradation. exotoxin (PE) pose major public health challenges. This interaction is proposed to allow translocation to the cytosol Both toxins depend on host cell machinery for inter- without resulting in toxin degradation (Johannes and Ro¨ mer, nalization, retrograde trafficking from endosomes 2010). to the ER, and translocation to cytosol. Although Obviously, this complex set of membrane-trafficking and both toxins follow a similar intracellular route, it is membrane-translocation events involves many host proteins, some of which have already been described (Johannes and unknown how much they rely on the same genes. Ro¨ mer, 2010; Sandvig et al., 2010). Altering the function of these Here we conducted two genome-wide RNAi screens host proteins could in theory provide a toxin antidote. identifying genes required for intoxication and Consistently, inhibition of retrograde traffic by drugs such as demonstrating that requirements are strikingly Brefeldin A (Sandvig et al., 1991)(Yoshida et al., 1991) or Golgi- different between PE and Ricin, with only 13% over- cide A (Sa´ enz et al., 2009) and Retro-1 and 2 (Stechmann et al., lap.
  • S100A10 in Cancer Progression and Chemotherapy Resistance: a Novel Therapeutic Target Against Ovarian Cancer

    S100A10 in Cancer Progression and Chemotherapy Resistance: a Novel Therapeutic Target Against Ovarian Cancer

    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 15 October 2018 doi:10.20944/preprints201810.0318.v1 Peer-reviewed version available at Int. J. Mol. Sci. 2018, 19, 4122; doi:10.3390/ijms19124122 Review S100A10 in Cancer Progression and Chemotherapy Resistance: A Novel Therapeutic Target against Ovarian Cancer Tannith M Noye1, Noor A Lokman1 Martin K Oehler1, 2 and Carmela Ricciardelli1,* 1 Discipline of Obstetrics and Gynaecology, Adelaide Medical School, Robinson Research Institute, The University of Adelaide, Adelaide, South Australia, Australia emails: [email protected] (T.M.N.); [email protected] (N.A.L.); [email protected] (M.K.O); [email protected](C.R) 2 Department of Gynaecological Oncology, Royal Adelaide Hospital, Adelaide, South Australia, Australia * Correspondence: [email protected]; Tel.: +61-0883138255 Abstract: S100A10, which is also known as p11 is located in the plasma membrane and forms a heterotetramer with annexin A2. The heterotetramer, comprising of 2 subunits of annexin A2 and S100A10, activates the plasminogen activation pathway which is involved in cellular repair of normal tissues. Increased expression of annexin A2 and S100A10 in cancer cells leads to increased levels of plasmin which promote degradation of the extracellular matrix, increased angiogenesis and invasion of the surrounding organs. Although many studies have investigated the functional role of annexin A2 in cancer cells including ovarian cancer, S100A10 has been less studied. We recently demonstrated that high stromal annexin A2 and high cytoplasmic S100A10 expression is associated with a 3.4 fold increased risk of progression and 7.9 fold risk of death in ovarian cancer patients.
  • Differential Proteomic Analysis of the Pancreas of Diabetic Db/Db Mice Reveals the Proteins Involved in the Development of Complications of Diabetes Mellitus

    Differential Proteomic Analysis of the Pancreas of Diabetic Db/Db Mice Reveals the Proteins Involved in the Development of Complications of Diabetes Mellitus

    Int. J. Mol. Sci. 2014, 15, 9579-9593; doi:10.3390/ijms15069579 OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Article Differential Proteomic Analysis of the Pancreas of Diabetic db/db Mice Reveals the Proteins Involved in the Development of Complications of Diabetes Mellitus Victoriano Pérez-Vázquez 1,*, Juan M. Guzmán-Flores 1, Daniela Mares-Álvarez 1, Magdalena Hernández-Ortiz 2, Maciste H. Macías-Cervantes 1, Joel Ramírez-Emiliano 1 and Sergio Encarnación-Guevara 2 1 Depto. de Ciencias Médicas, División de Ciencias de la Salud, Campus León, Universidad de Guanajuato, León, Guanajuato 37320, Mexico; E-Mails: [email protected] (J.M.G.-F.); [email protected] (D.M.-A.); [email protected] (M.H.M.-C.); [email protected] (J.R.-E.) 2 Centro de Ciencias Genómicas, Universidad Nacional Autónoma de México, Cuernavaca, Morelos 62210, Mexico; E-Mails: [email protected] (M.H.-O.); [email protected] (S.E.-G.) * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +52-477-7143-812; Fax: +52-477-7167-623. Received: 4 April 2014; in revised form: 14 May 2014 / Accepted: 19 May 2014 / Published: 30 May 2014 Abstract: Type 2 diabetes mellitus is characterized by hyperglycemia and insulin-resistance. Diabetes results from pancreatic inability to secrete the insulin needed to overcome this resistance. We analyzed the protein profile from the pancreas of ten-week old diabetic db/db and wild type mice through proteomics. Pancreatic proteins were separated in two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) and significant changes in db/db mice respect to wild type mice were observed in 27 proteins.
  • Conserved and Novel Properties of Clathrin-Mediated Endocytosis in Dictyostelium Discoideum" (2012)

    Conserved and Novel Properties of Clathrin-Mediated Endocytosis in Dictyostelium Discoideum" (2012)

    Rockefeller University Digital Commons @ RU Student Theses and Dissertations 2012 Conserved and Novel Properties of Clathrin- Mediated Endocytosis in Dictyostelium Discoideum Laura Macro Follow this and additional works at: http://digitalcommons.rockefeller.edu/ student_theses_and_dissertations Part of the Life Sciences Commons Recommended Citation Macro, Laura, "Conserved and Novel Properties of Clathrin-Mediated Endocytosis in Dictyostelium Discoideum" (2012). Student Theses and Dissertations. Paper 163. This Thesis is brought to you for free and open access by Digital Commons @ RU. It has been accepted for inclusion in Student Theses and Dissertations by an authorized administrator of Digital Commons @ RU. For more information, please contact [email protected]. CONSERVED AND NOVEL PROPERTIES OF CLATHRIN- MEDIATED ENDOCYTOSIS IN DICTYOSTELIUM DISCOIDEUM A Thesis Presented to the Faculty of The Rockefeller University in Partial Fulfillment of the Requirements for the degree of Doctor of Philosophy by Laura Macro June 2012 © Copyright by Laura Macro 2012 CONSERVED AND NOVEL PROPERTIES OF CLATHRIN- MEDIATED ENDOCYTOSIS IN DICTYOSTELIUM DISCOIDEUM Laura Macro, Ph.D. The Rockefeller University 2012 The protein clathrin mediates one of the major pathways of endocytosis from the extracellular milieu and plasma membrane. Clathrin functions with a network of interacting accessory proteins, one of which is the adaptor complex AP-2, to co-ordinate vesicle formation. Disruption of genes involved in clathrin-mediated endocytosis causes embryonic lethality in multicellular animals suggesting that clathrin-mediated endocytosis is a fundamental cellular process. However, loss of clathrin-mediated endocytosis genes in single cell eukaryotes, such as S.cerevisiae (yeast), does not cause lethality, suggesting that clathrin may convey specific advantages for multicellularity.
  • Serine Proteases with Altered Sensitivity to Activity-Modulating

    Serine Proteases with Altered Sensitivity to Activity-Modulating

    (19) & (11) EP 2 045 321 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 08.04.2009 Bulletin 2009/15 C12N 9/00 (2006.01) C12N 15/00 (2006.01) C12Q 1/37 (2006.01) (21) Application number: 09150549.5 (22) Date of filing: 26.05.2006 (84) Designated Contracting States: • Haupts, Ulrich AT BE BG CH CY CZ DE DK EE ES FI FR GB GR 51519 Odenthal (DE) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • Coco, Wayne SK TR 50737 Köln (DE) •Tebbe, Jan (30) Priority: 27.05.2005 EP 05104543 50733 Köln (DE) • Votsmeier, Christian (62) Document number(s) of the earlier application(s) in 50259 Pulheim (DE) accordance with Art. 76 EPC: • Scheidig, Andreas 06763303.2 / 1 883 696 50823 Köln (DE) (71) Applicant: Direvo Biotech AG (74) Representative: von Kreisler Selting Werner 50829 Köln (DE) Patentanwälte P.O. Box 10 22 41 (72) Inventors: 50462 Köln (DE) • Koltermann, André 82057 Icking (DE) Remarks: • Kettling, Ulrich This application was filed on 14-01-2009 as a 81477 München (DE) divisional application to the application mentioned under INID code 62. (54) Serine proteases with altered sensitivity to activity-modulating substances (57) The present invention provides variants of ser- screening of the library in the presence of one or several ine proteases of the S1 class with altered sensitivity to activity-modulating substances, selection of variants with one or more activity-modulating substances. A method altered sensitivity to one or several activity-modulating for the generation of such proteases is disclosed, com- substances and isolation of those polynucleotide se- prising the provision of a protease library encoding poly- quences that encode for the selected variants.